LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 54.27 | 17.25 | 44 | 4884 | 0.0090 | 0.1218 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 54.27 | 17.25 | 5376 | 4884 | 1.1007 | 1.0237 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 54.27 | 17.25 | 5702 | 4884 | 1.1675 | 1.0384 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 54.27 | 17.25 | 5748 | 4884 | 1.1769 | 1.0404 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 56.24 | 17.25 | 31 | 4929 | 0.0063 | 0.0745 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 56.24 | 17.25 | 5728 | 4929 | 1.1621 | 1.0372 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 56.24 | 17.25 | 6021 | 4929 | 1.2215 | 1.0497 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 56.24 | 17.25 | 6078 | 4929 | 1.2331 | 1.0520 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.21 | 17.25 | 27 | 4942 | 0.0055 | 0.0564 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.21 | 17.25 | 6138 | 4942 | 1.2419 | 1.0538 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.21 | 17.25 | 6385 | 4942 | 1.2919 | 1.0637 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 58.21 | 17.25 | 6425 | 4942 | 1.3000 | 1.0653 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.18 | 17.25 | 36 | 5031 | 0.0072 | 0.0940 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.18 | 17.25 | 6438 | 5031 | 1.2795 | 1.0611 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.18 | 17.25 | 6804 | 5031 | 1.3523 | 1.0751 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.18 | 17.25 | 6842 | 5031 | 1.3598 | 1.0765 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.15 | 17.25 | 27 | 5061 | 0.0053 | 0.0562 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.15 | 17.25 | 6762 | 5061 | 1.3361 | 1.0720 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.15 | 17.25 | 7138 | 5061 | 1.4104 | 1.0857 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 63.15 | 17.25 | 7173 | 5061 | 1.4173 | 1.0869 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 65.12 | 17.25 | 50 | 5095 | 0.0098 | 0.1385 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 65.12 | 17.25 | 7049 | 5095 | 1.3835 | 1.0807 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 65.12 | 17.25 | 7396 | 5095 | 1.4516 | 1.0929 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 65.12 | 17.25 | 7440 | 5095 | 1.4602 | 1.0944 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.09 | 17.25 | 50 | 5221 | 0.0096 | 0.1378 | MN20160310_N02 | K14 |